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A B S T R A C T
Purpose: Most deep brain stimulation targets for movement disorders were derived from effective
ablative surgery targets. Similarly effective lesion targets for epilepsy control may help reﬁne brain
stimulation targeting for epilepsy. A literature review of past stereotactic lesions for epilepsy treatment
was performed to provide historical context and possible anatomical guidance for current and future
attempts at controlling epilepsy with electrical stimulation. This work was undertaken to provide
insights for electrical stimulation targets in epilepsy treatment based on outcomes from previous
ablative therapies.
Methods: A MEDLINE search was conducted for studies with the words ‘‘stereotactic surgery’’ and
‘‘epilepsy.’’ Post-operative results for 619 patients with stereotactic brain lesions targeting various
anatomical foci were standardized using a modiﬁed Engel scale (1 ‘free of seizures’ to 3 ‘no signiﬁcant
improvement’). Each individual patient was entered into a database as a unique data point.
Results: There was a statistically signiﬁcant difference in reported seizure control among the different
procedures and seizure types. The procedures that produced the best seizure control outcomes were the
hippocampectomy, pallido-amygdalotomy, and amygdalohippocampectomy. Simple partial motor and
combined generalized tonic clonic with complex partial seizure types demonstrated the best outcomes
following surgery; complex partial and generalized tonic had the worst outcomes.
Conclusions: The results of this study demonstrate the location of brain lesions has a signiﬁcant effect on
seizure control. Thus, future research designed to optimize brain stimulation targets for epilepsy control
may be informed by previous ablative outcomes.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Epilepsy affects 4–8 out of 1000 people worldwide,1 and is
characterized by recurrent seizures. Trauma is one of the two
leading causes of epilepsy in the adult population younger than 65
years of age.2 Twenty to 30% of patients with epilepsy are not
adequately controlled with medications,3 and only one-third of
these patients are candidates for traditional surgical resections
leaving a signiﬁcant portion of this population with persistent
seizures.4 Even among the paucity of patients in the United States
with evaluations at Epilepsy Centers of Excellence,5 many are not
candidates for surgical resection because: they present with a
seizure focus that cannot be removed without causing signiﬁcant
disability, they have more than one focus of seizure activity, or they* Corresponding author at: Inova Department of Neurosciences, 3300 Gallows
Road, Falls Church, VA 22042, USA. Tel.: +1 703 776 8310; fax: +1 703 776 4018.
E-mail address: james.leiphart@inova.org (J.W. Leiphart).
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http://dx.doi.org/10.1016/j.seizure.2013.10.006do not have an identiﬁable seizure focus. Thus, strategies to
electrically stimulate the brain are being developed as potential
therapies to control intractable seizures.6–15
Stimulation strategies for the control of epilepsy vary widely,
and multiple brain regions have been targeted with devices similar
to those used for the treatment of movement disorders. Initial
stimulation targets in patients with movement disorders were
developed in light of prior experience with stereotactic lesions. In a
similar way, clinical outcomes following stereotactic lesions in
patients with epilepsy may help reﬁne brain stimulation in the
treatment of refractory epilepsy. To this end, we have performed a
systematic review of stereotactic lesions for the treatment of
epilepsy to evaluate the efﬁcacy of each target lesion.
2. Methods
A PubMed search was conducted using the words ‘‘epilepsy,’’
‘‘surgery,’’ and ‘‘stereotactic.’’ Searches were limited to include
only human subjects, and no date boundaries were set. Studiesvier Ltd. All rights reserved.
Table 1
Number of patients analyzed by region of stereotactic lesion surgery for epilepsy.36–77
Area of lesion Number of patients
Amygdalohippocampectomy 78
Amygdalotomy 169
Capsulotomy 16
Cingulotomy 9
Cortical Lesionectomy 38
Dentatolysis 8
Forelotomy 96
Fornico-amygdalotomy 33
Fornicotomy 55
Fornicotomy with commisurotomy 33
Hippocampectomy 10
Hypothalotomy 24
Pallido-amygdalotomy 7
Pallidotomy 5
Putaminectomy 24
Thalamotomy 14
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Surgery were also included. This search returned 391 articles
initially considered for this literature review, with dates ranging
from 1965 to 2005. Strict inclusion criteria for the studies were
used. To be included, each study must have employed focally-
targeted stereotactic surgeries with one or two anatomical targets,
patients must have undergone objective pre- and post-operative
evaluations by a physician, and each study must have included
lesions for the treatment of epilepsy. Moreover, only the longest
patient follow-up data for each group of investigators was
included, as some articles were written periodically on patients
as they were followed for many years. Once these criteria had been
met, our ﬁnal dataset consisted of 619 patients treated with
stereotactic lesions for epilepsy from 42 different studies.
These 619 patients were then standardized according to a 3
point modiﬁed Engel scale based on post-operative physician
evaluations. This scale ranged from 1 to 3, with 1 corresponding to
a seizure free outcome, 2 indicating signiﬁcant reduction in
seizures, and 3 indicating minimal or no reduction in seizures. This
scale was used as the dependent variable for analysis.
Patients were divided into groups according to their ablative
procedure. This resulted in 26 groups. Groups containing less than
5 patients were not analyzed due to their low statistical power. The
remaining 16 procedure groups from 42 studies including 619
subjects with their distributions are shown in Table 1. A Kruskal-
Wallis test was performed to determine if there was a statistically
signiﬁcant difference in the outcomes from the 16 different
anatomical targets using StatView1.
Not all of the studies had clinical information that allowed for
classiﬁcation of seizure type. The studies with seizure classiﬁcation
data were also compared by seizure type using a Kruskal-Wallis
test. This included 241 subjects from 21 studies.
3. Results
The Kruskal-Wallis analysis determined that there was a
statistically signiﬁcant difference in seizure control outcomes
among the different procedures shown in Fig. 1 (p = 0.026). The
hippocampectomy (modiﬁed Engel scale: 1.4), pallido-amygda-
lotomy (1.71), and amygdalohippocampectomy (1.77) procedures
resulted in the best seizure control outcomes. However, outcomes
were poorest in patients undergoing cingulotomies (2.55),
dentatolysis (2.36) and putamenectomies (2.13).Fig. 1. Average post-operative seizure control outcomes by target region for stereotactic l
signiﬁcant reduction in seizures, and (3) no signiﬁcant reduction in seizures.There was also a statistically signiﬁcant difference in seizure
control outcomes for different seizure types (p = 0.0018,
Fig. 2). Patients with simple partial motor and those with
combined generalized tonic–clonic with complex partial seizures
demonstrated the best outcomes. Complex partial and generalized
tonic types showed the worst outcomes.
Table 2 shows the average seizure control outcome using the
modiﬁed Engel scale for each lesion location by seizure type in
patients with this data available. The low number of patients and
missing data in several categories made meaningful statistical
analysis impossible.
4. Discussion
Brain stimulation techniques for the control of epilepsy7,16–20
include two basic approaches. In one approach a speciﬁc target,
typically a nucleus or region of the cortex, is stimulated in an effort
to reduce seizure frequency via effects through the entire brain.20
This method is advantageous since it can be utilized in patients
who do not have a localized seizure focus. In the other approach,
the identiﬁed seizure focus or foci are directly stimulated in an
effort to disrupt seizures at their source.19 Although this requires
an identiﬁed seizure focus, the advantage of this approach is thatesion epilepsy surgeries. Modiﬁed Engel scale: (1) representing seizure freedom, (2)
Fig. 2. Average post-operative seizure control outcomes by seizure type for stereotactic lesion epilepsy surgeries. Modiﬁed Engel scale: (1) representing seizure freedom, (2)
signiﬁcant reduction in seizures, and (3) no signiﬁcant reduction in seizures.
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electrophysiological evidence of seizure onset can be identiﬁed.
Unlike the ﬁrst approach, which requires continuous or pulsed
stimulation, responsive stimulation has the potential to require
less overall device output, and therefore a smaller battery source.
Both methods have included stimulation parameters similar to
those utilized in deep brain stimulation for movement disor-
ders.8,14 Both methods have been utilized in an attempt to control
seizures of various types originating from a variety of loca-
tions.19,20
Although the mechanisms by which deep brain stimulation
modulates movement disorders are incompletely understood,
many investigators believe that it acts by inhibiting or blocking the
stimulated brain region, similar to the effects of stereotactic
lesions.21,22 Non-seizure focus stimulation has been applied to
various regions of the brain including the subthalamic nucleus,8,10
hippocampus,12,23,24 anterior thalamus,9,25 centromedian thala-
mus,11,25 cerebellum,26–28 and caudate.29 Attempts to stimulate
the seizure focus/foci have also utilized several different targets,
including the hippocampus and various cortical regions.6,7 In
addition to ﬁndings from the above studies, historical lesion
experience in seizure control may help guide the choice of
stimulation targets. Stereotactic lesion surgery has the advantages
of lower cost and elimination of the need for permanently
implanted device which is at risk of infection, breakage, malfunc-
tion and would necessarily require a reoperation at some point for
replacement of the electrical generator. The advantages of
implanting a stimulator over producing a stereotactic lesion are
the reversibility and adaptability of the therapy.
Except for the subthalamic nucleus, lesion targets analyzed in
the present study were similar to the various targets utilized in
stimulation studies. These included lesions of the hippocampus,Table 2
Table of average post-operative seizure control outcomes by seizure type and target reg
seizure freedom, (2) signiﬁcant reduction in seizures, and (3) no signiﬁcant reduction in s
CP: complex partial; GT: generalized tonic; GTC: generalized tonic clonic; SP: simple p
CP GT GTC 
Amygdalohippocampectomy 1.7 (23) – 
Amygdalotomy 2.1 (18) – 
Capsulotomy – 1.5 (4) 
Cortical lesionectomy – – 
Dentatolysis – – 
Forelotomy 3.0 (11) 2.2 (11) 
Fornico-amygdalotomy 2.1 (7) – 
Fornicotomy 2.2 (12) – 
Hypothalotomy – – thalamus, and cerebellum. In addition, many other regions were
lesioned in the analyzed studies, suggesting the possibility of other
potential targets. Not surprisingly, hippocampal lesions produced
the best seizure reduction outcomes. This procedure is essentially a
hippocampectomy utilizing a minimally invasive stereotactic
approach. Open anterior temporal lobectomy with hippocampect-
omy has been extensively studied, and has demonstrated the best
seizure control outcomes among all epilepsy surgery proce-
dures.30–32 Moreover, hypothalotomy patients demonstrated good
seizure control outcomes, as this procedure was performed
exclusively for the treatment of hypothalamic hamartomas.
Likewise, lesional epilepsy surgeries tended to have better
outcomes than non-lesional surgeries. Of interest, the amygdala
was not targeted for stimulation, although the amygdalotomy
resulted in better seizure control outcomes when utilized in
combination with lesions at other sites like the amygdalohippo-
campectomy, the fornico-amygdalotomy, and the pallodo-amyg-
dalotomy. Nonetheless, amygdalotomy alone did not produce
clinically signiﬁcant seizure control outcomes. Thalamotomy and
cortical lesionectomy procedures demonstrated favorable seizure
control outcomes – providing further justiﬁcation for their use as
targets in the larger clinical studies of brain stimulation for
epilepsy.6,7,16–18 Of note, one procedure that had surprisingly good
seizure control outcomes was the forelotomy. The ﬁelds of Forel
have not been stimulated for attempted seizure control, but this
region may deserve consideration in future studies. The closest
analogous procedure to cerebellum stimulation would be the
dentatolysis, which had poor seizure control outcomes.
Many of the studies reviewed had sufﬁcient detail to draw
conclusions concerning seizure control outcomes from stereotactic
lesions. Patients showing the greatest reduction in seizures were
those that had simple partial motor seizures. This was unexpectedion for stereotactic lesion epilepsy surgeries. Modiﬁed Engel scale: (1) representing
eizures. The number within the parentheses is the number of patients in each group.
artial.
GTC/CP SP Motor SP Psychic
– – – –
1.5 (13) 1.0 (2) – 1.0 (1)
2.2 (11) – – –
– 1.0 (2) 1.0 (4) –
2.0 (4) – 2.7 (3) –
1.4 (32) 2.3 (3) 1.3 (20) –
– – – –
1.9 (42) – – –
– – 1.8 (12)
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partial seizures did not have the best post-operative outcomes.33
Second, the stereotactic lesion surgeries that demonstrated the
best outcomes were those that had hippocampectomies. Complex
partial seizures are associated with hippocampal onset, so complex
partial seizures would be expected to have the best outcomes.34
This may be due to inconsistent reporting of seizure types among
the various studies. Only 39% of the patients with reported
outcome data had reliable information to determine seizure type.
Combined generalized tonic clonic and complex partial seizures
had the next best outcomes. These cases probably represented
complex partial seizures with secondary generalization. These
good outcomes agree with epilepsy surgery studies that showed
the best outcomes with complex partial seizures.35 Complex
partial seizures alone had the worst post-operative outcomes from
stereotactic lesion surgeries. Again, this surprising result calls into
question the determination of seizure type in these studies.
5. Conclusions
This study was designed to review potentially useful historical
data concerning seizure control outcomes from stereotactic brain
lesions. Lesions involving the hippocampus, amygdala, thalamus,
and cortical foci showed the best seizure reduction outcomes. This
corresponds with targets currently used in brain stimulation for
epilepsy control. Seizure types that responded best to stereotactic
lesioning were simple partial seizures and combined generalized
tonic clonic/complex partial seizures. These ﬁndings may help
optimize the selection of targets and patients appropriate for
stimulation epilepsy surgery.
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